Feb. 5 at 8:03 PM
$SION @S_Franconi Orbimed sold 1/3 of their SION stock, and Orbimed’s independent director sold some stock too. So the SP dropped by 20%. If Orbimed lost confidence, they would have sold out. I’m holding my shares.
BTW - SION is currently testing cystic fibrosis therapeutics. They expect to have top line read outs from their SION-719 phase 2 trial and both ph1 combo therapy trials in mid 2026.
